With regard to tumor stage, CD44 was more frequently expressed in stage III (68.06 ± 8.09, p < 0.0001) and stage II (61.96 ± 7.25, p = 0.002) than stage I (50.95 ± 3.66), leading to a significant difference between stage II and III(p = 0.018). The gene discussed is CD44; the disease is neoplasm.